Al-Azhar Journal of Pharmaceutical Sciences

Abdelzaher, Arafat FORMULATION AND CHARACTERIZATION OF THERMOSENSITIVE CHITOSAN HYDROGEL LOADED WITH ERLOTINIB: FULL FACTORIAL DESIGN OF RELEASE DATA [Volume 68, Issue 2, 2023, Pages 1-27]
Abo-Senna, Amal S MONITORING OF RABIES IMMUNE STATUS IN EXPERIMENTALLY VACCINATED PUPPIES [Volume 68, Issue 2, 2023, Pages 172-187]
Abuelghait, Mohamed CORRELATION BETWEEN BIOFILM OF DENTAL MICROBES AND ANTIBIOTIC RESISTANCE, IN VITRO STUDY [Volume 68, Issue 2, 2023, Pages 188-205]
Afouna, Mohsen M PREPARATION AND CHARACTERIZATION OF ATROPINE SULFATE ORODISPERSIBLE TABLETS [Volume 68, Issue 2, 2023, Pages 43-63]
Ahmed, Ahmed Mohamed Ahmed DEVELOPMENT AND VALIDATION OF LC-MS METHOD FOR SIMULTANEOUS DETERMINATION OF PYRIMETHAMINE AND SULFADOXINE IN THE PHARMACEUTICAL PREPARATION [Volume 68, Issue 2, 2023, Pages 159-171]
Alhalafwy, Asmaa CORRELATION BETWEEN BIOFILM OF DENTAL MICROBES AND ANTIBIOTIC RESISTANCE, IN VITRO STUDY [Volume 68, Issue 2, 2023, Pages 188-205]
Aref, Mostafa Mohammed AN OVERVIEW OF QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS [Volume 68, Issue 2, 2023, Pages 130-158]
Ayyad, Rezk R VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS [Volume 68, Issue 2, 2023, Pages 111-129]

Dahab, Mohammed A AN OVERVIEW OF QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS [Volume 68, Issue 2, 2023, Pages 130-158]

Eissa, Ibrahim H PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 64-81]
El-Olemy, Ahmed DEVELOPMENT AND VALIDATION OF LC-MS METHOD FOR SIMULTANEOUS DETERMINATION OF PYRIMETHAMINE AND SULFADOXINE IN THE PHARMACEUTICAL PREPARATION [Volume 68, Issue 2, 2023, Pages 159-171]
Elwan, Alaa PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 64-81]
Elwan, Alaa VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS [Volume 68, Issue 2, 2023, Pages 111-129]
El-Zahabi, Mohamed Ayman ALy PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 64-81]
El-Zahabi, Mohamed Ayman ALy EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 82-110]
El-Zahabi, Mohamed Ayman ALy AN OVERVIEW OF QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS [Volume 68, Issue 2, 2023, Pages 130-158]
Emam, Mohamed H PREPARATION AND CHARACTERIZATION OF ATROPINE SULFATE ORODISPERSIBLE TABLETS [Volume 68, Issue 2, 2023, Pages 43-63]
Emara, Mohamed S DEVELOPMENT AND VALIDATION OF LC-MS METHOD FOR SIMULTANEOUS DETERMINATION OF PYRIMETHAMINE AND SULFADOXINE IN THE PHARMACEUTICAL PREPARATION [Volume 68, Issue 2, 2023, Pages 159-171]

Gebreel, Hassan M CORRELATION BETWEEN BIOFILM OF DENTAL MICROBES AND ANTIBIOTIC RESISTANCE, IN VITRO STUDY [Volume 68, Issue 2, 2023, Pages 188-205]

Hegazy, Dalia N MONITORING OF RABIES IMMUNE STATUS IN EXPERIMENTALLY VACCINATED PUPPIES [Volume 68, Issue 2, 2023, Pages 172-187]
Hosseny, Ebtesam N MONITORING OF RABIES IMMUNE STATUS IN EXPERIMENTALLY VACCINATED PUPPIES [Volume 68, Issue 2, 2023, Pages 172-187]

Ibrahim, Mohamed F PREPARATION AND CHARACTERIZATION OF ATROPINE SULFATE ORODISPERSIBLE TABLETS [Volume 68, Issue 2, 2023, Pages 43-63]

Khodeir, Mohamed H MONITORING OF RABIES IMMUNE STATUS IN EXPERIMENTALLY VACCINATED PUPPIES [Volume 68, Issue 2, 2023, Pages 172-187]

Marzouk, Adel A EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 82-110]
Mohamed, Abeer A AN OVERVIEW OF QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS [Volume 68, Issue 2, 2023, Pages 130-158]
Mohammed, Ahmed FORMULATION AND CHARACTERIZATION OF THERMOSENSITIVE CHITOSAN HYDROGEL LOADED WITH ERLOTINIB: FULL FACTORIAL DESIGN OF RELEASE DATA [Volume 68, Issue 2, 2023, Pages 1-27]
Mohammed, Ahmed FORMULATION AND CHARACTERIZATION OF DIFFERENT TOPICAL HYDROGELS LOADED WITH SILDENAFIL CITRATE [Volume 68, Issue 2, 2023, Pages 28-42]
Mowafy, Hammam A PREPARATION AND CHARACTERIZATION OF ATROPINE SULFATE ORODISPERSIBLE TABLETS [Volume 68, Issue 2, 2023, Pages 43-63]

Nassar, Mohamed W DEVELOPMENT AND VALIDATION OF LC-MS METHOD FOR SIMULTANEOUS DETERMINATION OF PYRIMETHAMINE AND SULFADOXINE IN THE PHARMACEUTICAL PREPARATION [Volume 68, Issue 2, 2023, Pages 159-171]

Osman, Shaaban K. FORMULATION AND CHARACTERIZATION OF THERMOSENSITIVE CHITOSAN HYDROGEL LOADED WITH ERLOTINIB: FULL FACTORIAL DESIGN OF RELEASE DATA [Volume 68, Issue 2, 2023, Pages 1-27]
Osman, Shaaban K. FORMULATION AND CHARACTERIZATION OF DIFFERENT TOPICAL HYDROGELS LOADED WITH SILDENAFIL CITRATE [Volume 68, Issue 2, 2023, Pages 28-42]
Otify, Islam VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS [Volume 68, Issue 2, 2023, Pages 111-129]
Ouf, Abdelsalam Mohamed EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 82-110]

Sakr, Helmy VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS [Volume 68, Issue 2, 2023, Pages 111-129]
Salem, Zeinab T MONITORING OF RABIES IMMUNE STATUS IN EXPERIMENTALLY VACCINATED PUPPIES [Volume 68, Issue 2, 2023, Pages 172-187]
Shykhoon, Montaser A EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 82-110]

Yaseen, Abobakr FORMULATION AND CHARACTERIZATION OF DIFFERENT TOPICAL HYDROGELS LOADED WITH SILDENAFIL CITRATE [Volume 68, Issue 2, 2023, Pages 28-42]
Yousef, Reda G PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 64-81]
Youssef, HebatAllah Ibrahim CORRELATION BETWEEN BIOFILM OF DENTAL MICROBES AND ANTIBIOTIC RESISTANCE, IN VITRO STUDY [Volume 68, Issue 2, 2023, Pages 188-205]